Are High- or Low-dose SGLT2 Inhibitors Associated With Cardiovascular and Respiratory Adverse Events? A Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Are High- or Low-dose SGLT2 Inhibitors Associated With Cardiovascular and Respiratory Adverse Events? A Meta-analysis

Published:2022-05 Issue:5 Volume:79 Page:655-662
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Zou Hai-Tao,Yang Guo-Huan,Cai Yu-Jun,Chen Hao,Zheng Xiao-Qin,Hu Rong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference37 articles.

1. Canagliflozin alleviates LPS-induced acute lung injury by modulating alveolar macrophage polarization;Lin;Int Immunopharmacol,2020

2. Empagliflozin and dulaglutide are effective against obesity-induced airway hyperresponsiveness and fibrosis in A murine model;Park;Sci Rep,2019

3. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension;Chowdhury;Biochem Biophys Res Commun,2020

4. Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study;Tang;Nutr Diabetes,2019

5. The effectiveness of dapagliflozin for sleep-disordered breathing among Japanese patients with obesity and type 2 diabetes mellitus;Furukawa;Endocr J,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: An electronic health database analysis;Heart & Lung;2024-11

2. The potential anti-arrhythmic effect of SGLT2 inhibitors;Cardiovascular Diabetology;2024-07-15

3. Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis;Frontiers in Pharmacology;2024-05-23

4. A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures;Acta Diabetologica;2024-05-07

5. The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs;European Journal of Clinical Pharmacology;2024-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3